Meet Sesen at DIA 2025 in Washington, D.C.
Join us June 15–19 at Booth #2013 to explore global clinical and regulatory language solutions.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.
Explore how Sesen delivers regulatory-grade translation and localization solutions for leading life sciences organizations. Each case study highlights real-world challenges, our strategic approach, and measurable results.
Each case study includes:
Client: Global Pharma | Region: Global
Client: Mid-size Biotech | Region: Japan
Client: Global Medical Device Manufacturer | Region: EU, APAC, LATAM
Client: U.S. MedTech Company | Region: EU
Client: Biopharma Marketing Team | Region: Global
Client: Emerging Biotech | Region: EU, LATAM
Client: HealthTech Company | Region: EU
Sesen is a trusted language partner exclusively serving the life sciences industry. Our proven success across complex translation projects is driven by deep subject matter expertise, regulatory alignment, and scalable global delivery.
We specialize in pharmaceuticals, biotechnology, medical devices, CROs, and public health—ensuring every project is handled by experts with domain-specific knowledge.
Our workflows are certified to ISO 17100, ISO 13485, and ISO 9001 standards, enabling consistent, audit-ready translations for EMA, FDA, PMDA, and other health authorities.
Whether supporting a multinational product launch or regional labeling updates, our agile teams manage multilingual projects across 150+ languages with precision and speed.
We integrate advanced AI tools like SesenGPT to enhance linguistic consistency, accelerate turnaround, and support machine translation post-editing (MTPE) for regulatory and clinical content.
All translations are performed by professional native linguists with subject matter expertise and supported by dedicated project managers who oversee quality, timelines, and compliance.
Discover how our life sciences–exclusive translation solutions drive global success across pharma, biotech, medical devices, and CROs.